Bristol-Myers Squibb
BMY
#195
Rank
S$152.57 B
Marketcap
S$74.71
Share price
-1.61%
Change (1 day)
28.50%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): S$4.57

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is S$4.62. In 2025 the company made an earnings per share (EPS) of S$4.49 an increase over its 2024 EPS that were of S-$5.73.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.571.85%
2025S$4.49-178.28%
2024S-$5.73-213.92%
2023S$5.0330.2%
2022S$3.86-6.04%
2021S$4.11-179.29%
2020S-$5.19-281.37%
2019S$2.86-27.21%
2018S$3.93
2016S$3.46175.26%
2015S$1.26-19.83%
2014S$1.57-22.44%
2013S$2.0234.48%
2012S$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.33 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.10 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.70-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.67-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.60 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.78 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.32-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$12.12 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.61-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$9.01 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK